Evidence map›Paper›PMID 31168101›Full record

ArticleNature neuroscience2019

Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability.

Joëlle A Pasman, Karin J H Verweij, Zachary Gerring, Sven Stringer, Sandra Sanchez-Roige, Jorien L Treur, Abdel Abdellaoui, Michel G Nivard, Bart M L Baselmans, Jue-Sheng Ong and 41 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

51 authors.

Joëlle A PasmanBehavioural Science Institute, Radboud University, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0001-7558-0482
Karin J H VerweijBehavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
Zachary GerringGenetic Epidemiology, Statistical Genetics, and Translational Neurogenomics Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Sven StringerDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-3115-8532
Sandra Sanchez-RoigeDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Jorien L TreurMRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK.
Abdel AbdellaouiAmsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, The Netherlands.
Michel G NivardDepartment of Biological Psychology/Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-2015-1888
Bart M L BaselmansDepartment of Biological Psychology/Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Jue-Sheng OngGenetic Epidemiology, Statistical Genetics, and Translational Neurogenomics Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-6062-710X
Hill F IpDepartment of Biological Psychology/Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-1991-5019
Matthijs D van der ZeeDepartment of Biological Psychology/Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Meike BartelsDepartment of Biological Psychology/Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-9667-7555
Felix R DayMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.ORCID http://orcid.org/0000-0003-3789-7651
Pierre Fontanillas23andMe, Inc., Mountain View, CA, USA.
Sarah L Elson23andMe, Inc., Mountain View, CA, USA.
23andMe Research Team
Harriet de WitDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
Lea K DavisVanderbilt Genetics Institute; Division of Genetic Medicine, Department of Medicine, Vanderbilt University, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-5143-2282
James MacKillopPeter Boris Centre for Addictions Research and Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University/St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.ORCID http://orcid.org/0000-0003-4118-9500
Substance Use Disorders Working Group of the Psychiatric Genomics Consortium
International Cannabis Consortium
Jaime L DerringerDepartment of Psychology, University of Illinois Urbana-Champaign, Champaign, IL, USA.
Susan J T BranjeDepartment of Youth and Family, Utrecht University, Utrecht, the Netherlands.
Catharina A HartmanDepartment of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Andrew C HeathDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Pol A C van LierDepartment of Developmental Psychology and EMGO Institute for Health and Care Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Pamela A F MaddenDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Reedik MägiEstonian Genome Center, University of Tartu, Tartu, Estonia.
Wim MeeusDepartment of Youth and Family, Utrecht University, Utrecht, the Netherlands.
Grant W MontgomeryInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-4140-8139
A J OldehinkelDepartment of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.ORCID http://orcid.org/0000-0003-3925-3913
Zdenka PausovaHospital for Sick Children, Toronto, Ontario, Canada.
Josep A Ramos-QuirogaPsychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Tomas PausRotman Research Institute, Baycrest, Toronto, Ontario, Canada.
Marta RibasesPsychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-1039-1116
Jaakko KaprioInstitute for Molecular Medicine Finland FIMM, HiLIFE Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-3716-2455
Marco P M BoksBrain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0001-6163-7484
Jordana T BellDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Tim D SpectorDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Joel GelernterDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-4067-1859
Dorret I BoomsmaDepartment of Biological Psychology/Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Nicholas G MartinGenetic Epidemiology, Statistical Genetics, and Translational Neurogenomics Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Stuart MacGregorGenetic Epidemiology, Statistical Genetics, and Translational Neurogenomics Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0001-6731-8142
John R B PerryMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.
Abraham A PalmerDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3634-0747
Danielle PosthumaDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-7582-2365
Marcus R MunafòMRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK.ORCID http://orcid.org/0000-0002-4049-993X
Nathan A GillespieGenetic Epidemiology, Statistical Genetics, and Translational Neurogenomics Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Eske M DerksGenetic Epidemiology, Statistical Genetics, and Translational Neurogenomics Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-6292-6883
Jacqueline M VinkBehavioural Science Institute, Radboud University, Nijmegen, The Netherlands. j.vink@bsi.ru.nl.ORCID http://orcid.org/0000-0003-3910-3528

Funding

Medical Research Council MC_UU_12015/2
6 · The paper itself

Abstract

Several occurrences of the word 'schizophrenia' have been re-worded as 'liability to schizophrenia' or 'schizophrenia risk', including in the title, which should have been "GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability," as well as in Supplementary Figures 1-10 and Supplementary Tables 7-10, to more accurately reflect the findings of the work.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.